Multiomic Analysis Reveals an IFN-driven Cellular Landscape Effectively Targeted by Ruxolitinib in Hailey-Hailey Disease
Sara Ceccacci, Hoang Duc Minh Pham, Marion Dessaignes, Jasmin Mirzayan, Kévin Roger, Lam C. Tsoi, Paul W. Harms, Johann Eli Gudjonsson, Emilia Puig Lombardi, Ida Chiara Guerrera, Alain Hovnanian
This study uses multiomic analysis to identify IFN signaling as a key driver in Hailey-Hailey disease and shows that ruxolitinib treatment reduces inflammation and improves patient outcomes.
bioRxiv · Jun 4, 2026 · PreprintPathology